Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Guang Xie

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|October 4, 2005
Additional discussions regarding the altered metabolism and transport of omeprazole after long-term use of St John's wortHong-Guang Xie
Pharmacology & Therapeutics|February 16, 2010
Personalized immunosuppressive therapy in pediatric heart transplantation: Progress, pitfalls and promisesHong-Guang Xie
Personalized Medicine|May 24, 2018
Pharmacogenomics steps toward personalized medicineHong-Guang Xie, Felix W Frueh
Clinical Pharmacology and Therapeutics|July 9, 2005
St John's wort-associated drug interactions: short-term inhibition and long-term induction?Hong-Guang Xie, Richard B Kim
Pharmacogenomics|March 7, 2006
Gene variants in noncoding regions and their possible consequencesGuang-Ji Wang, Ping Yang, Hong-Guang Xie
Arthritis and Rheumatism|May 10, 2005
Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug responseYu Asanuma, Hong-Guang Xie, C Michael Stein
Journal of Cardiovascular Pharmacology|August 18, 2017
Overcoming Clopidogrel Resistance: Three Promising Novel Antiplatelet Drugs Developed in ChinaHong-Guang Xie, Yu-Meng Jia, Ting Tai, et al.
Clinical and Experimental Pharmacology & Physiology|August 23, 2006
Effects of individual ginsenosides, ginkgolides and flavonoids on CYP2C19 and CYP2D6 activity in human liver microsomesNu He, Hong-Guang Xie, Xavier Collins, et al.
Pharmacogenetics and Genomics|September 3, 2011
Lower tacrolimus daily dose requirements and acute rejection rates in the CYP3A5 nonexpressers than expressersHui-Lin Tang, Hong-Guang Xie, Yao Yao, et al.
Pharmacology & Therapeutics|September 29, 2012
Qualified kidney biomarkers and their potential significance in drug safety evaluation and predictionHong-Guang Xie, Shu-Kui Wang, Chang-Chun Cao, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|October 4, 2005
Additional discussions regarding the altered metabolism and transport of omeprazole after long-term use of St John's wortHong-Guang Xie
Pharmacology & Therapeutics|February 16, 2010
Personalized immunosuppressive therapy in pediatric heart transplantation: Progress, pitfalls and promisesHong-Guang Xie
Personalized Medicine|May 24, 2018
Pharmacogenomics steps toward personalized medicineHong-Guang Xie, Felix W Frueh
Clinical Pharmacology and Therapeutics|July 9, 2005
St John's wort-associated drug interactions: short-term inhibition and long-term induction?Hong-Guang Xie, Richard B Kim
Pharmacogenomics|March 7, 2006
Gene variants in noncoding regions and their possible consequencesGuang-Ji Wang, Ping Yang, Hong-Guang Xie
Arthritis and Rheumatism|May 10, 2005
Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug responseYu Asanuma, Hong-Guang Xie, C Michael Stein
Journal of Cardiovascular Pharmacology|August 18, 2017
Overcoming Clopidogrel Resistance: Three Promising Novel Antiplatelet Drugs Developed in ChinaHong-Guang Xie, Yu-Meng Jia, Ting Tai, et al.
Clinical and Experimental Pharmacology & Physiology|August 23, 2006
Effects of individual ginsenosides, ginkgolides and flavonoids on CYP2C19 and CYP2D6 activity in human liver microsomesNu He, Hong-Guang Xie, Xavier Collins, et al.
Pharmacogenetics and Genomics|September 3, 2011
Lower tacrolimus daily dose requirements and acute rejection rates in the CYP3A5 nonexpressers than expressersHui-Lin Tang, Hong-Guang Xie, Yao Yao, et al.
Pharmacology & Therapeutics|September 29, 2012
Qualified kidney biomarkers and their potential significance in drug safety evaluation and predictionHong-Guang Xie, Shu-Kui Wang, Chang-Chun Cao, et al.
Pageof 7